Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-126827

Chief Legal Officer sold 10,702 shares at $18.47 ($197,666)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sullivan Mark · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-25 Sale : show line 1 in the form 10b5-1 −10,702 $18.47 $197,666 271,079 D
Open-market sales · 10,702 sh · avg $18.47 · $197,666
Loading xslF345X06/ownership.xml…